ETON
Eton Pharmaceuticals Stock Analysis
AI Rating
- Quality2/10
- Growth↓ 4/10
- Value↓ 1/10
ETON Growth
- Revenue Y/Y↑ 72.89%
- EPS Y/Y↑ 73.68%
- FCF Y/Y↑ 179.55%
ETON Profitability
- Gross margin ↑ 54.80%
- EPS margin↓ -1.70%
- ROIC 5Y↓ -31.95%
ETON Risk
- Debt / Equity↓ 1.0
- Debt / FCF↓ 0.7
- Interest coverage↓ 0.6
Eton Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.